These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15405)

  • 41. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
    JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
    Vetter W; Vetter H; Beckerhoff R; Redlich B; Cottier P; Siegenthaler W
    Klin Wochenschr; 1976 Jul; 54(14):661-3. PubMed ID: 979066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R; Vetter H; Kramer HJ
    Nephron; 1980; 25(4):187-92. PubMed ID: 6990285
    [No Abstract]   [Full Text] [Related]  

  • 47. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diuretic therapy and response of essential hypertension to saralasin.
    Anderson GH; Dalakos TG; Elias A; Tomycz N; Streeten DH
    Ann Intern Med; 1977 Aug; 87(2):183-7. PubMed ID: 889199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 52. Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension.
    Mann JF; Dietz R; Ritz E; Ganten D
    Eur J Pharmacol; 1983 Sep; 92(3-4):207-13. PubMed ID: 6628541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
    Dalakos TG; Elias AN; Anderson GH; Streeten DH; Schroeder ET
    J Clin Endocrinol Metab; 1978 Jan; 46(1):114-8. PubMed ID: 752014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition.
    Plouin PF; Chatellier G; Rougeot MA; Comoy E; Ménard J; Corvol P
    J Hypertens; 1988 Jul; 6(7):579-85. PubMed ID: 2902135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of angiotensin II receptor activity in chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    Am Heart J; 1984 Jul; 108(1):81-9. PubMed ID: 6328965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of (1sarcosine, 8isoleucine) angiotensin II analogue on the adrenal cortex and medullary hormones].
    Mizuno K; Haruyama K; Miura T; Ogawa S; Nakajima G
    Horumon To Rinsho; 1977 Oct; 25(10):1125-9. PubMed ID: 589811
    [No Abstract]   [Full Text] [Related]  

  • 57. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baroreceptor reflex in the rat after converting enzyme inhibition or angiotensin receptor blockade.
    Coleman TG; Salgado MC; Bengis RG; Davis MH; Dent AC
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):79-82. PubMed ID: 6258832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.